Qian Xing Selected Research

Qian Xing Research Topics

Disease

6	Type 2 Diabetes Mellitus (MODY) 01/2021 - 08/2009
4	Inflammation (Inflammations) 02/2024 - 01/2017
4	Hypothyroidism 09/2018 - 02/2011
4	Atherosclerosis 08/2017 - 08/2009
3	Insulin Resistance 11/2013 - 08/2009
2	Lupus Nephritis 08/2022 - 01/2012
2	Hyperglycemia 02/2022 - 11/2009
2	Neoplasms (Cancer) 01/2022 - 03/2020
2	Myocarditis (Carditis) 01/2022 - 03/2020
2	Hypertension (High Blood Pressure) 03/2020 - 11/2009
2	Ankylosing Spondylitis 09/2019 - 08/2005
2	Dyslipidemias (Dyslipidemia) 02/2011 - 11/2009
1	Body Weight (Weight, Body) 02/2024
1	Diarrhea 01/2024
1	Infections 01/2024
1	Pneumonia (Pneumonitis) 08/2023
1	Thrombophlebitis 07/2023
1	Shock 01/2023
1	Neoplasm Metastasis (Metastasis) 12/2022
1	Sepsis (Septicemia) 04/2022
1	Critical Illness (Critically Ill) 02/2022
1	Esophageal Squamous Cell Carcinoma 02/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Nasopharyngeal Carcinoma 01/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 06/2021
1	Gout 03/2021
1	Gouty Arthritis 03/2021
1	Osteoporosis 01/2021
1	Cushing Syndrome 09/2020
1	Idiopathic Noncirrhotic Portal Hypertension 03/2020
1	Myasthenia Gravis 03/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 03/2020
1	Adenocarcinoma of Lung 03/2020
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 03/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2019
1	Leukemia 05/2019
1	Insulinoma 01/2019
1	Esophageal Neoplasms (Esophageal Cancer) 12/2018
1	Vitamin D Deficiency 05/2017
1	Dry Eye Syndromes (Dry Eye Syndrome) 05/2017

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 02/2024 - 09/2018
3	Immune Checkpoint InhibitorsIBA 08/2023 - 03/2020
3	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2012
3	MicroRNAs (MicroRNA)IBA 08/2022 - 09/2018
2	Interleukin-17 (Interleukin 17)IBA 02/2024 - 04/2012
2	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2017
2	Uric Acid (Urate)IBA 03/2021 - 01/2020
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 08/2014
2	Insulin Glargine (Lantus)FDA Link 01/2021 - 08/2014
2	C-Reactive ProteinIBA 08/2017 - 08/2005
2	Selenoproteins (Selenoprotein)IBA 04/2016 - 11/2013
2	IodineIBA 06/2011 - 06/2011
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 02/2011 - 01/2011
2	HDL CholesterolIBA 02/2011 - 08/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024
1	vitexinIBA 02/2024
1	OccludinIBA 01/2024
1	AntioxidantsIBA 01/2024
1	CatalaseIBA 01/2024
1	Secretory Immunoglobulin A (SIgA)IBA 01/2024
1	Immunoglobulin G (IgG)IBA 01/2024
1	Malondialdehyde (Propanedial)IBA 01/2024
1	Volatile Oils (Essential Oils)IBA 01/2024
1	Superoxide DismutaseIBA 01/2024
1	gadolinium ethoxybenzyl DTPA FDA Link 12/2022
1	Transcription Factor CHOPIBA 04/2022
1	Endoplasmic Reticulum Chaperone BiPIBA 04/2022
1	Blood Glucose (Blood Sugar)IBA 02/2022
1	Therapeutic UsesIBA 01/2022
1	SteroidsIBA 01/2022
1	tofacitinibIBA 01/2022
1	PoisonsIBA 06/2021
1	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2020
1	Methylprednisolone FDA LinkGeneric 03/2020
1	Monoclonal AntibodiesIBA 03/2020
1	Phosphocreatine (Neoton)IBA 03/2020
1	Phosphotransferases (Kinase)IBA 03/2020
1	Cholinergic ReceptorsIBA 03/2020
1	Immunoglobulins (Immunoglobulin)IBA 03/2020
1	sintilimabIBA 03/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2019
1	Adalimumab (Humira)FDA Link 09/2019
1	Biosimilar PharmaceuticalsIBA 09/2019
1	Protein Kinases (Protein Kinase)IBA 05/2019
1	JNK Mitogen-Activated Protein KinasesIBA 05/2019
1	CalciumIBA 01/2019
1	SYBR Green IIBA 09/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2018
1	Messenger RNA (mRNA)IBA 09/2018
1	brain-derived neurotrophic factor precursorIBA 09/2018
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2018
1	hydroxide ionIBA 05/2017
1	Vitamin D FDA LinkGeneric 05/2017
1	kallistatinIBA 01/2017

Therapy/Procedure

5	Therapeutics 12/2022 - 11/2009
1	Catheters 07/2023
1	Indwelling Catheters (Indwelling Catheter) 07/2023
1	Fluid Therapy (Oral Rehydration Therapy) 01/2023
1	Esophagectomy 02/2022
1	Radiotherapy 12/2018